Clinical trials recruiting in Stockholm, Sweden
195
Recruiting trials
15
Conditions
Phase breakdown
Early Phase 1 2Phase 1 14Phase 2 25Phase 3 73Phase 4 4Not applicable 91
Conditions recruiting in Stockholm, Sweden
| Condition | Trials |
|---|---|
| Heart Failure | 21 |
| Breast Cancer | 18 |
| Colorectal Cancer | 17 |
| Prostate Cancer | 17 |
| Lung cancer | 13 |
| Depression | 12 |
| Anxiety | 11 |
| Chronic Kidney Disease | 11 |
| Atrial Fibrillation | 10 |
| Hypertension | 10 |
| Melanoma | 10 |
| Pancreatic Cancer | 10 |
| Obesity | 8 |
| Type 2 Diabetes | 8 |
| Crohn's Disease | 6 |
Recruiting trials in Stockholm, Sweden
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- A First-In-Human Trial of pTTL in Advanced Colorectal Cancer
- A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer
- A Long-term Extension Study of PCI-32765 (Ibrutinib)
- A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
- A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis
- A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Acupuncture or Metformin for Insulin Resistance in Women With PCOS
- Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease
- Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
- Adjuvant Melatonin for Uveal Melanoma
- Aerobic Versus Leisure Group for Adolescents With Depression
- Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
- Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
- Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
- BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
- Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)
- Body-oriented Psychotherapy for Individuals With a History of Child Maltreatment and Trauma-related Symptoms
- Brain Connectivity Marker for Alzheimer's Disease
- Cancer Related Major Depression Treated With a Single Dose of Psilocybin
- Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation
- Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
- Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
- Cognitive Behavior Therapy in Psychiatric Inpatient Care
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
- Contact Radiotherapy for Rectal Cancer
- Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants
- D-SOLVE Cohorts (Cohort a and B)
- DESTINY Breast Respond HER2-(Ultra)Low Europe
- Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension
- Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS)
- Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE
- Eatit's Obesity Intervention: Effects on Weight, Eating Habits and Health
- Effect of Nitrate on Red Blood Cell Function in Type 2 Diabetes
- Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
- Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
- Efficacy of Hyperthermic Intraperitoneal Chemotherapy
- Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
- European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
- Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial
- Excessive Supraventricular Activity and Atrial Fibrillation
- Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
- First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis
- First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
- HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking
- ICBT for OCD in Children With Autism
- IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
- Improving CRT Outcome With Non-Invasive Cardiac Mapping
- Induction Chemotherapy for Locally Recurrent Rectal Cancer
- Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
- International (Pediatric) Peritoneal Biobank
Showing 100 of 195 recruiting trials.
Common questions
How many clinical trials are recruiting in Stockholm, Sweden?
195 recruiting trials have at least one study site in Stockholm, Sweden.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.